Contrasting Editas Medicine (NASDAQ:EDIT) & OpGen (OPGN) – StockNewsTimes
Contrasting Editas Medicine (NASDAQ:EDIT) & OpGen (OPGN)StockNewsTimesIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) c… Continue reading
